Business · 31/01/2013Updated: 10/17/2026 · 1 min read
FDA to Hold Public Hearing on ALS Drug Regulation
Summary
The Food and Drug Administration (FDA) is hosting a public hearing to gather input from patients, healthcare providers, and industry experts on the regulation of drugs for treating amyotrophic lateral sclerosis (ALS).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →